COVID-19 Vaccine: USF Health and TGH selected to participate in the Novavax Phase 3 clinical trial
USF Health and Tampa General Hospital have been selected as a site for a clinical trial testing the Novavax NVX-CoV2373 vaccine for COVID-19. They join over 100 research sites expecting to enroll more than 30,000 adult participants as part of the global search for a safe and effective vaccine toContinue Reading